n-methyl-3,4-methylenedioxyamphetamine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Dimpfel, W; Nichols, DE; Spüler, M | 1 |
| Gudelsky, GA; Nash, JF; Yamamoto, BK | 1 |
| Huang, X; Nichols, DE | 1 |
| Ashby, CR; Granoff, MI | 1 |
| Aguirre, N; Barrionuevo, M; Del Río, J; Lasheras, B | 1 |
| Colado, MI; Elliott, JM; Green, AR; Mechan, AO; O'Shea, E | 1 |
| Bull, EJ; Fone, KC; Hutson, PH | 1 |
| Cunningham, KA; Frankel, PS; Herin, DV; Ross, JD; Thomas, ML | 1 |
| Biezonski, DK; Courtemanche, AB; Hong, SB; Meyer, JS; Piper, BJ | 1 |
| Brennan, KA; Colussi-Mas, J; Jones, K; Schenk, S | 1 |
| Cassels, BK; Díaz-Véliz, G; Mora-Gutiérrez, S; Quinteros-Muñoz, D; Rebolledo-Fuentes, M; Sáez-Briones, P | 1 |
| Abbas, AI; Beck, SG; Crawford, LK; Deneris, ES; Farrell, MS; Gingrich, J; Huang, XP; Irwin, JJ; Keiser, MJ; Kroeze, WK; Piel, DA; Roth, BL; Sciaky, N; Setola, V; Shoichet, BK; Yadav, PN | 1 |
| Bastos, Mde L; Capela, JP; Carvalho, F; Costa, VM; da Costa Araújo, S; Dirnagl, U; Fernandes, E; Meisel, A; Ruscher, K | 1 |
| Gogos, A; Thwaites, SJ; Van den Buuse, M | 1 |
| Gołembiowska, K; Kamińska, K; Kreiner, G; Noworyta-Sokołowska, K; Rogóż, Z | 1 |
16 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Brain; Central Nervous System Stimulants; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electroencephalography; Evoked Potentials; Hallucinogens; Injections, Intraperitoneal; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred F344; Telemetry | 1989 |
Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.
Topics: Amphetamines; Analysis of Variance; Animals; Corpus Striatum; Dopamine; Injections, Subcutaneous; Male; Methoxydimethyltryptamines; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Receptor Agonists | 1994 |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hippocampus; Hydrazines; Indans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
The effect of the repeated administration of the compound 3,4-methylenedioxymethamphetamine on the response of rats to the 5-HT2A,C receptor agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
Topics: Amphetamines; Animals; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 1998 |
The role of dopaminergic systems in the perinatal sensitivity to 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in rats.
Topics: Age Factors; Amphetamines; Animals; Body Temperature; Brain; Carrier Proteins; Dopamine; Female; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1998 |
A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation.
Topics: Amphetamines; Animals; Body Temperature; Body Temperature Regulation; Brain Chemistry; Hallucinogens; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Piperazines; Rats; Serotonin; Serotonin Receptor Agonists | 2001 |
Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.
Topics: Amphetamines; Animals; Brain; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Protein Binding; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Social Behavior | 2004 |
Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].
Topics: Amphetamines; Analysis of Variance; Animals; Behavior, Animal; Down-Regulation; Hallucinogens; Humans; Immunohistochemistry; Male; N-Methyl-3,4-methylenedioxyamphetamine; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Agonists; Serotonin Agents; Serotonin Receptor Agonists | 2006 |
Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist.
Topics: Amphetamines; Animals; Behavior, Animal; Brain; Corticosterone; Ketanserin; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurosecretory Systems; Prolactin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Serotonin Agents | 2009 |
Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
Topics: Amphetamines; Animals; Brain; Dose-Response Relationship, Drug; Drug Tolerance; Exploratory Behavior; Fenfluramine; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 2010 |
Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.
Topics: Amphetamines; Animals; Avoidance Learning; Behavior, Animal; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Hallucinogens; Male; Maze Learning; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley | 2010 |
The presynaptic component of the serotonergic system is required for clozapine's efficacy.
Topics: Acoustic Stimulation; Action Potentials; Adrenergic Uptake Inhibitors; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Checkpoint Kinase 2; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; Ketanserin; Lysine; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Patch-Clamp Techniques; Phencyclidine; Presynaptic Terminals; Protein Binding; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Radioligand Assay; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Reflex, Startle; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Tritium; Tryptophan Hydroxylase | 2011 |
The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons.
Topics: Amphetamines; Animals; Apoptosis Inducing Factor; Biomarkers; Blotting, Western; Caspase 3; Caspase 8; Cell Survival; Cells, Cultured; Cytochromes c; Dose-Response Relationship, Drug; Gestational Age; Hallucinogens; Hippocampus; L-Lactate Dehydrogenase; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neurotoxicity Syndromes; Primary Cell Culture; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Time Factors | 2013 |
Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: effect of MDMA, DOI and 8-OH-DPAT.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Evoked Potentials; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Schizophrenia; Sensory Gating | 2013 |
Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.
Topics: 5-Methoxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Analysis of Variance; Animals; Corpus Striatum; DNA Damage; Dopamine; Frontal Lobe; Glutamic Acid; Hallucinogens; Illicit Drugs; Male; Microdialysis; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Oxidative Stress; Rats, Wistar; Serotonin | 2016 |